274 related articles for article (PubMed ID: 31793175)
1. Metabolic changes during malignant transformation in primary cells of oral lichen planus: Succinate accumulation and tumour suppression.
Yang Q; Sun H; Wang X; Yu X; Zhang J; Guo B; Hexige S
J Cell Mol Med; 2020 Jan; 24(2):1179-1188. PubMed ID: 31793175
[TBL] [Abstract][Full Text] [Related]
2. CD133 expression in oral lichen planus correlated with the risk for progression to oral squamous cell carcinoma.
Sun L; Feng J; Ma L; Liu W; Zhou Z
Ann Diagn Pathol; 2013 Dec; 17(6):486-9. PubMed ID: 23911820
[TBL] [Abstract][Full Text] [Related]
3. Bmi1 expression in oral lichen planus and the risk of progression to oral squamous cell carcinoma.
Ma L; Wang H; Yao H; Zhu L; Liu W; Zhou Z
Ann Diagn Pathol; 2013 Aug; 17(4):327-30. PubMed ID: 23639414
[TBL] [Abstract][Full Text] [Related]
4. Clinical value and potential circulating of miR-99a as tumor suppressor biomarker in serum of oral squamous cell carcinoma and erosive atrophic lichen planus.
Farshbaf A; Mohtasham N; Shamshiri AK; Khazaeni K; Aghaee-Bakhtiari SH; Arab F; Cheshomi M; Hassanabadi M; Mohajertehran F
J Stomatol Oral Maxillofac Surg; 2024 Jun; 125(3S):101806. PubMed ID: 38408642
[TBL] [Abstract][Full Text] [Related]
5. A genome-wide association scan of biological processes involved in oral lichen planus and oral squamous cell carcinoma.
Yang Q; Xu B; Sun H; Wang X; Zhang J; Yu X; Ma X
Medicine (Baltimore); 2017 Jun; 96(25):e7012. PubMed ID: 28640079
[TBL] [Abstract][Full Text] [Related]
6. Role of TP53 in the progression of pre-malignant and malignant oral mucosal lesions. A follow-up study of 144 patients.
Ogmundsdóttir HM; Björnsson J; Holbrook WP
J Oral Pathol Med; 2009 Aug; 38(7):565-71. PubMed ID: 19473450
[TBL] [Abstract][Full Text] [Related]
7. Oral lichen planus has a high rate of TP53 mutations. A study of oral mucosa in icelanD.
Ogmundsdóttir HM; Hilmarsdóttir H; Astvaldsdóttir A; Jóhannsson JH; Holbrook WP
Eur J Oral Sci; 2002 Jun; 110(3):192-8. PubMed ID: 12120703
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of MYC status in oral lichen planus in patients with progression to oral squamous cell carcinoma.
Segura S; Rozas-Muñoz E; Toll A; Martín-Ezquerra G; Masferrer E; Espinet B; Rodriguez M; Baró T; Barranco C; Pujol RM
Br J Dermatol; 2013 Jul; 169(1):106-14. PubMed ID: 23461699
[TBL] [Abstract][Full Text] [Related]
9. Aldehyde dehydrogenase 1 expression correlated with malignant potential of oral lichen planus.
Xu Z; Shen Z; Shi L; Sun H; Liu W; Zhou Z
Ann Diagn Pathol; 2013 Oct; 17(5):408-11. PubMed ID: 23707659
[TBL] [Abstract][Full Text] [Related]
10. Update of the cancer-associated molecular mechanisms in oral lichen planus, a disease with possible premalignant nature.
Georgakopoulou EA; Troupis TG; Troupis G; Gorgoulis VG
J BUON; 2011; 16(4):613-6. PubMed ID: 22331711
[TBL] [Abstract][Full Text] [Related]
11. Markers of Oral Lichen Planus Malignant Transformation.
Tampa M; Caruntu C; Mitran M; Mitran C; Sarbu I; Rusu LC; Matei C; Constantin C; Neagu M; Georgescu SR
Dis Markers; 2018; 2018():1959506. PubMed ID: 29682099
[TBL] [Abstract][Full Text] [Related]
12. Unveiling the Potential of Serum MiR-483-5p: A Promising Diagnostic and Prognostic Biomarker in OLP and OSCC Patients by
Soltaninezhad P; Arab F; Mohtasham N; FakherBaheri M; Kavishahi NN; Aghaee-Bakhtiari SH; Zare-Mahmoodabadi R; Pakfetrat A; Taban KI; Mohajertehran F
Curr Pharm Des; 2024; 30(4):310-322. PubMed ID: 38310566
[TBL] [Abstract][Full Text] [Related]
13. Clinical behaviour of malignant transforming oral lichen planus.
Mignogna MD; Lo Russo L; Fedele S; Ruoppo E; Califano L; Lo Muzio L
Eur J Surg Oncol; 2002 Dec; 28(8):838-43. PubMed ID: 12477475
[TBL] [Abstract][Full Text] [Related]
14. Oxidative stress status and DNA damage in saliva of human subjects with oral lichen planus and oral squamous cell carcinoma.
Agha-Hosseini F; Mirzaii-Dizgah I; Farmanbar N; Abdollahi M
J Oral Pathol Med; 2012 Nov; 41(10):736-40. PubMed ID: 22582895
[TBL] [Abstract][Full Text] [Related]
15. Decreased expression of p63 in oral lichen planus and graft-vs.-host disease associated with oral inflammation.
Ebrahimi M; Wahlin YB; Coates PJ; Sjöström B; Nylander K
J Oral Pathol Med; 2006 Jan; 35(1):46-50. PubMed ID: 16393253
[TBL] [Abstract][Full Text] [Related]
16. Podoplanin and ABCG2: malignant transformation risk markers for oral lichen planus.
Shi P; Liu W; Zhou ZT; He QB; Jiang WW
Cancer Epidemiol Biomarkers Prev; 2010 Mar; 19(3):844-9. PubMed ID: 20200437
[TBL] [Abstract][Full Text] [Related]
17. Dysregulation of TCONS_00006091 contributes to the elevated risk of oral squamous cell carcinoma by upregulating SNAI1, IRS and HMGA2.
Ma D; Chen J; Shi Y; Gao H; Wei Z; Fan J; Wang L
Sci Rep; 2024 Apr; 14(1):9616. PubMed ID: 38671227
[TBL] [Abstract][Full Text] [Related]
18. Oral lichen planus shows higher expressions of tumor suppressor gene products of p53 and p21 compared to oral mucositis. An immunohistochemical study.
Safadi RA; Al Jaber SZ; Hammad HM; Hamasha AA
Arch Oral Biol; 2010 Jun; 55(6):454-61. PubMed ID: 20427035
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-137 promoter methylation in oral lichen planus and oral squamous cell carcinoma.
Dang J; Bian YQ; Sun JY; Chen F; Dong GY; Liu Q; Wang XW; Kjems J; Gao S; Wang QT
J Oral Pathol Med; 2013 Apr; 42(4):315-21. PubMed ID: 23121285
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of premalignant potential in oral lichen planus using interphase cytogenetics.
Kim J; Yook JI; Lee EH; Ryu MH; Yoon JH; Hong JC; Kim DJ; Kim HS
J Oral Pathol Med; 2001 Feb; 30(2):65-72. PubMed ID: 11168849
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
